echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Science Advances: Cancer cells are masters of hypnotism?

    Science Advances: Cancer cells are masters of hypnotism?

    • Last Update: 2022-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In our impression, cancer cells are like a vicious thug, but in fact, the life of cancer cells is not easy, and they are always facing the siege from the immune system


    However, a new study from the University of Ottawa has discovered a new ability of cancer cells - "hypnotic" NK cells, blood cancer cells will transfer the cell membrane with PD-1 to NK cells, making them "dormant" ” state, thereby inhibiting their anticancer activity


    To "hypnotize" NK cells, blood cancer cells transfer their membranes with PD-1 to NK cells, causing them to enter a "dormant" state, thereby inhibiting their anticancer activity


    When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer Science Advances

    The fight against cancer is a battlefield without gunpowder smoke.


    PD-1/PD-L1 immune checkpoint blockade therapy is one of the most effective immunotherapies at present


    PD-1/PD-L1

    PD-1/PD-L1

    In this latest study, the research team found that a type of contact between cells, trogocytosis, can explain this doubt


    Cytognathism leads to the transfer of PD-1 from tumor cells to NK cells

    Cytognathism leads to the transfer of PD-1 from tumor cells to NK cells

    In a mouse model of leukemia, the research team found that cytotoxicity between lymphocytes and tumor cells is very frequent, which also causes NK cells and CD8+ T cells to acquire PD-1 from leukemia cells


    Intratumoral lymphocytes acquire PD-1 from tumor cells in a leukocyte mouse model

    Intratumoral lymphocytes acquire PD-1 from tumor cells in a leukocyte mouse model

    From this point of view, the NK cell is not only a ruthless "killer" but also a "thief" - stealing the cell membranes carrying surface protein molecules from other blood cells


    In patients with clonal plasma cell disease, the researchers confirmed by immunohistochemistry the cytotoxic effect of NK cells on blood cancer cells—not only PD-1 but also tumor cell markers


    PD-1 and CD138 are also present in NK cells from patients with clonal plasmacytosis

    PD-1 and CD138 are also present in NK cells from patients with clonal plasmacytosis

    Michele Ardolino, Ph.


    Altogether, this study elucidates a novel mechanism for regulating NK cell function by acquiring PD-1 from tumor cells


    This study elucidates a novel mechanism for regulating NK cell function by acquiring PD-1 from tumor cells


    Original Source: Original Source:

    MOHAMED S.


    MOHAMED S.
    HASIM, et al.
    When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer.
    SCIENCE ADVANCES, 13 Apr 2022, Vol 8, Issue 15.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.